// App-Quantinova.ai

BSH19‐PO‐116 : Most haematological abnormalities in neonates with Down syndrome are transient but dysplastic myelopoiesis persists throughout early childhood

Researchers

Presenter

  • L. Hanssen

Principal Investigators

  • N. Bhatnagar

  • A. Chaussade

  • L. Nizery

  • N. Elliott

  • A. Kennedy

  • M. Metzner

  • A. Norton

  • G. Hall

  • P. Vyas

  • I. Roberts

Medical Centers

  • MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine,University of

  • Department of Paediatrics, Oxford University Hospitals

  • Paediatrics, MRC Weatherall Institute of Molecular Medicine

  • Department of pediatrics,

  • MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine,University of

  • Department of Haematology and Oncology, Radcliffe Department of Medicine and NIHR BRC Biomedical Research Centre, Oxford University Hospital and University of Oxford

  • Birmingham Women's and Children's Hospital, Birmingham

  • Department of Haematology and Oncology, Radcliffe Department of Medicine and NIHR BRC Biomedical Research Centre, Oxford University Hospital and University of Oxford

  • MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Department of Paediatrics, NIHR BRC Biomedical Research Centre, University of Oxford, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Myelodysplastic Syndrome

  • Down syndrome

  • Macrocytosis

Biomarkers

  • Breakpoint Cluster Region

  • Stromal interaction molecule 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved